Channel
@debalkdaru
On this record: Growth · Engagement · What this channel posts · Posts · Citations · Cite this entry
98subscribers
+3 since we began measuring on 6 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
| Telegram ID | -1001278670773 |
|---|---|
| Type | Channel |
| Username | @debalkdaru |
| Created | Between 1 April 2018 and 31 July 2021— estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 9 August 2026 |
| Last confirmed live | 21 August 2026 |
| Measurements held | 4 |
| Confirmed unchanged | 1 time, most recently 21 August 2026 |
| On Telegram | t.me/debalkdaru |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 21 Aug 2026, 16:57 | 98 | +2 |
| 14 Aug 2026, 22:38 | 96 | +1 |
| 9 Aug 2026, 12:31 | 95 | no change |
| 6 Aug 2026, 09:03 | 95 | first reading |
17 posts held, back to 4 January 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.
ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.
ER is defined industry-wide as (forwards + reactions + comments) ÷ views— note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.
| Window | Rolling 30 days · latest post in window 30 July 2026 |
|---|---|
| Posts held | 17 (4 January 2026 – 30 July 2026) |
| Views total | 12 |
| Reactions total | — |
| Forwards / comments | not exposed by the public surface — not measured, not estimated |
| Readings taken | 9 Aug 2026, 12:31 UTC |
Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.
Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.
Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.
Measured directly from 1 video with a duration reading, out of the posts we hold for this channel — not this channel’s whole posting history, only the sample this register has actually read. An exact reading to the second, taken from the post itself rather than from Telegram’s own rounded chrome, so it carries no ≈ mark.
🔷 مدنیزاده: شیوه فعلی قیمتگذاری دارو پاسخگو نیست* ✅یکی از صریحترین مواضع یکصدوسیوهفتمین نشست دیروز شورای گفتوگوی دولت و بخش خصوصی، *انتقاد وزیر اقتصاد از مدل فعلی قیمتگذاری دارو* بود. ✅مدنیزاده با بیان اینکه روش موجود، حقوق تولیدکنندگان را به طور کامل تأمین نمیکند، گفت: وزارت بهداشت و سازمان غذا و دارو باید با مشارکت بخش خصوصی، *سازوکاری منطقیتر برای تعیین قیمت دارو طراحی کنند*؛ مدلی که ضمن حفظ توان تولیدک…
🔷گزارش های بهار ۱۴۰۵ شرکت های داروسازی 🌐بهین بورس
🔷گزارش های بهار ۱۴۰۵ شرکت های داروسازی 🌐بهین بورس
🔵 بررسی هلدینگهای دارویی 🔵 🔴 در این پست به بررسی ۵ هلدینگ دارویی فعال در بازار سرمایه پرداختیم. علاوه بر ارزیابی سود خالص و خالص ارزش داراییهای(NAV) هر شرکت، جزئیات پورتفو بورسی هر کدام نیز مورد ارزیابی قرار گرفت. 🌐انیگما
🔷بررسی وضعیت بنیادی صنعت دارو 🌐علی اسکینی
#دبالک 📉 مقايسه عملکرد نماد دبالک از گروه مواد و محصولات دارویی در میزان فروش و سود دهی در یکسال گذشته. 📊🍽 🌐علی محمودیان
🔷تحلیل پیشرفته گزارش های حسابرسی صنعت دارو 🌐دکتر سیاوش افتخاری
🔷 بازدهی یک ساله گروه داروئی
تحلیل عملکرد صنعت دارویی (شرکتهای بورس اوراق بهادار - ۱۴۰۴) 🌐فانا
🔷بررسی گزارشهای ماهانه گروه محصولات دارویی* 🔷 اعداد به میلیارد تومان میباشد و نمادها بر اساس درصد تغییر دو ماهه 1405 به دو ماهه 1404 رتبهبندی شدهاند. 🌐 تحلیل بازار بورس ایران
✅ رابطه ارز ترجیحی و گرانی دارو 🔷 همایون سامهیح نجف آبادی عضو کمیسیون بهداشت و درمان مجلس: تا زمانی که ارز ترجیحی در اختیار تولیدکنندگان قرار نگیرد، ناچارند از ارز آزاد استفاده کنند و این امر باعث تاثیر مستقیم بر قیمت دارو و سایر فرآوردههای سلامتمحور میشود. 🔷 بر اساس قانون اگر ارز ترجیحی برای تولید دارو یا سایر فرآورده های سلامت محور تامین نشود و تولیدکننده با کمبود مواجه شود از ارز آزاد برای تولید استفاده می…
🔴 ارز ۲۸۵۰۰ دارو فعلاً سر جایش است 🔷حسین تاجیک مدیر اداره تخصیص ارز بانک مرکزی امروز در اتاق بازرگانی تهران: نرخ ارز ۲۸۵۰۰ تومانی برای دارو و تجهیزات پزشکی همچنان پابرجا خواهد بود و دولت تا زمان حصول اطمینان از عدم بروز اختلال در زنجیره تامین این اقلام حیاتی، برنامهای برای حذف این نرخ ندارد 🔷درباره اختلاف نرخ ارز ترجیحی و نرخ بازار و فشاری که ممکن است به واردکنندگان وارد شود حل آن صرفا در اختیار بانک مرکزی نیست. م…
Showing the 12 most recent of 17 posts we hold for @debalkdaru. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Citation-graph rank — 38,251 of 1,604,161entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 21 August 2026 — this entry's latest reading, not the date you are reading this.
“دبالک” (@debalkdaru), 98 subscribers as measured 21 August 2026. Telegram Register, tgregister.com/channel/debalkdaru.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.